Peritoneal mesothelioma is a disease in which cancerous cells form in the peritoneum, which is the lining of the abdomen. Mesothelioma can also occur in the chest and scrotum. Many other health ...

R-DXd has previously shown promising clinical results in platinum-resistant ovarian, peritoneal, and fallopian tube cancers.

Actor Nafisa Ali has revealed that her ovarian and peritoneal cancer has returned, and she will now undergo chemotherapy ...

Raludotatug deruxtecan (R-DXd) has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with platinum-resistant ...

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, ...

Raludotatug deruxtecan has received breakthrough therapy designation for treatment of certain adults with platinum-resistant ...

The impact of guidelines on the treatment of endometrial cancer in Germany: A nationwide analysis of the AGO in 2006 and 2009. Background: To compare survival outcome and identify differences in ...

Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...

The US FDA has granted breakthrough therapy designation to the novel antibody-drug conjugate (ADC) raludotatug deruxtecan ...